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Porphyromonas gingivalis stimulates TACE production by T
cells
Abstract
INTRODUCTION: Tumour necrosis factor-alpha converting enzyme (TACE), also known as
ADAM17, is a membrane-bound metalloprotease and disintegrin. It is produced by a number of host
cells and is known to shed and release cell-bound cytokines, particularly members of the tumour
necrosis factor family. The aim of this study was to investigate the effect of Porphyromonas gingivalis
on TACE production by a human T-cell line, to identify putative virulence factors involved in this
process, and to investigate the effect of doxycycline. METHODS: P. gingivalis 6-day culture
supernatants were used to challenge Jurkat T cells for 6 h. Secreted and cell-associated TACE levels
were measured by enzyme-linked immunosorbent assay, whereas messenger RNA expression was
investigated by quantitative real-time polymerase chain reaction. To investigate the involvement of
cysteine proteases or proteinaceous components in general, P. gingivalis culture supernatants were
treated with the specific chemical inhibitor TLCK or heat-inactivated, respectively. The effect of
doxycycline on the regulation of TACE secretion by P. gingivalis was also investigated. RESULTS: P.
gingivalis challenge resulted in a concentration-dependent enhancement of TACE messenger RNA
expression and protein release by Jurkat cells. TLCK treatment or heat treatment of P. gingivalis culture
supernatants decreased TACE release to control levels. Doxycycline inhibited TACE secretion dose
dependently. CONCLUSION: The induction of TACE by T cells in response to P. gingivalis may in
turn favour the shedding of host cell-bound cytokines into the local microenvironment, potentially
amplifying the inflammatory response. In the present experimental system, P. gingivalis cysteine
proteases are involved in TACE release by T cells.
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ABSTRACT 
Introduction: Tumor necrosis factor-α converting enzyme (TACE), also known as 
ADAM17, is a membrane bound metalloproteinase and disintegrin. It is produced by 
a number of host cells and it is known to shed and release cell-bound cytokines, 
particularly members of the tumor necrosis factor family. The aim of this study was to 
investigate the effect of Porphyromonas gingivalis on TACE production by a human 
T-cell line, identify putative virulence factors involved in this process, and investigate 
the effect of doxycycline. 
Methods: P. gingivalis 6-day culture supernatants were used to challenge Jurkat T-
cells for 6 h. Secreted and cell associated TACE levels were measured by ELISA, 
whereas mRNA expression was investigated by quantitative real-time PCR. To 
investigate the involvement of cysteine proteases, or proteinaceous components in 
general, P. gingivalis culture supernatants were treated with the specific chemical 
inhibitor TLCK, or heat-inactivated, respectively. The effect of doxycycline on the 
regulation of TACE secretion by P. gingivalis was also investigated. 
Results: P. gingivalis challenge resulted in a concentration-dependent enhancement of 
TACE mRNA expression and protein release by Jurkat cells.  TLCK- or heat-
treatment of P. gingivalis culture supernatants decreased TACE release to control 
levels. Doxycycline inhibited TACE secretion dose-dependently. 
Conclusion: The induction of TACE by T-cells in response to P. gingivalis may in 
turn favour the shedding of host cell-bound cytokines into the local 
microenvironment, potentially amplifying the inflammatory response.  In the present 
experimental system, P. gingivalis cysteine proteases are involved in TACE release 
by T-cells. 
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INTRODUCTION 
Porphyromonas gingivalis is Gram-negative black-pigmenting anaerobe, highly 
implicated in chronic periodontitis in humans (1). This species has also been shown to 
induce experimental periodontitis in animal models (2). The main putative virulence 
factors of this pathogen are its lipopolysaccharide (LPS) (3) and its Arg-X and Lys-X 
cysteine proteases (gingipains) (4), which are capable of perturbing local immunity 
and deregulating the host’s inflammatory response (5, 6). These virulence properties 
of P. gingivalis may favour its capacity to invade the deeper periodontal tissues and 
establish chronic inflammation (7). 
Tumor necrosis factor-α converting enzyme (TACE) is a member of the “A 
Disintegrin And Metalloprotease” (ADAM) family, namely ADAM17, with a 
cysteine-rich, a disintegrin and a zinc-dependent metalloprotease domain. It is 
constitutively expressed by several cell types, including T-cells and monocytes, either 
as a secreted, or a membrane-bound protein (8-11). Bacterial challenge is considered a 
major regulator of TACE expression (12, 13).  As a global “sheddase”, TACE aims at 
the proteolytic cleavage and release of the ectodomain of cell-membrane bound 
cytokines. In this manner, TACE can efficiently mobilize cytokines into the local 
microenvironment, which in turn can act in a paracrine manner to amplify their effects 
and establish inflammation (14). The substrates that TACE is able to shed are ligands 
and receptors highly associated with inflammation, such as tumor necrosis factor-α 
and its p55 receptor, transforming growth factor-α, interleukin-1 receptor II, receptor 
activator of NF-κB ligand, and epidermal growth factor receptor ligands (8, 11, 15, 
16).  
The involvement of TACE in rheumatoid arthritis (17) and tumour progression 
(18, 19) has been clearly demonstrated, and this enzyme is now considered a potential 
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target for drug development (16, 20). It was recently demonstrated that TACE may be 
of relevance to periodontal disease (21). It is detected in human gingival crevicular 
fluid (GCF), and its levels are elevated in periodontitis, compared to gingivitis 
patients or healthy subjects. Importantly, periodontitis patients under immuno-
suppressive treatment exhibit particularly low GCF TACE levels, indicating that T-
cells are a major source of this enzyme. This is perhaps not surprising since T-cells 
have a key role in the pathogenesis of periodontal disease (22, 23). 
Inhibition of TACE is considered an effective pharmacological target in 
inflammatory and neoplastic diseases (16), and potentially in periodontal diseases 
(24). Doxycycline is an antibiotic that has also been shown to exert anti-inflammatory 
properties, distinct from its antimicrobial ones (25). These properties have been 
utilised clinically in the treatment of inflammatory diseases (26), including 
periodontitis (27). Recent work using an in vivo infection model suggests that 
doxycycline may attenuate inflammation partly by targeting TACE, consequently 
resulting in reduced cytokine release (28).  
Nevertheless, the mechanisms of TACE regulation in response to periodontal 
pathogens have not been investigated. Since P. gingivalis is a potent inducer of T-cell 
responses (29, 30), there is merit to investigate TACE regulation in an in vitro system 
that involves P. gingivalis and T-cells. Therefore, the aim of this study was to 
investigate if P. gingivalis regulates TACE in a T-cell line, and to evaluate the 
putative involvement of its virulence factors in this. Furthermore, the effect of sub-
antimicrobial doses of doxycycline on TACE regulation by P. gingivalis was 
investigated. 
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MATERIALS AND METHODS 
Cell cultures 
Jurkat T-lymphocyte leukemia cells (E6-1; American Type Tissue Culture Collection) 
were maintained in RPMI Glutamax (Gibco BRL Life Technologies, UK) 
supplemented with 10% foetal bovine serum. The cells were harvested in the mid-log 
growth phase, and plated in 12-well tissue culture plates, at density 106 cells/well, in 1 
ml culture media. For the experiments, the cells were cultured in the presence or 
absence of P. gingivalis culture supernatants for 6 h. 
 
Bacterial cultures and growth conditions 
Porphyromonas gingivalis W50 wild-type strain was cultured blood agar base 
supplemented with 5% horse blood (Oxoid, Hampshire, UK) and maintained by 
weekly subculture for up to 5 weeks. Liquid cultures were prepared by inoculation of 
bacterial colonies (3-4 days old) from blood agar plates into 10 ml brain heart infusion 
broth (Oxoid, Hampshire, UK) supplemented with 5 mg/l hemin (Sigma, Dorset, UK), 
and incubated for 24 h. Ten percent inoculum was transferred to 90 ml of the same 
medium and incubated for 6 days. All cultures were grown at 37°C in a Don Whitley 
anaerobic cabinet, MACS MG500, in an atmosphere of 80% N2, 10% H2, and 10% 
CO2. After this culture period, bacteria were harvested by centrifugation at 10000 x g 
for 15 min at 4˚C and supernatants were collected, filter-sterilized over a 0.2 µm filter, 
and stored at -80˚C until use.  These P. gingivalis preparations were diluted in the 
cell-culture medium, and their concentration is expressed as total bacterial protein 
(µg/ml) present in the cell cultures. Protein concentration was determined by Bio-Rad 
Protein assay (Bio-Rad, Hertfordshire, UK). 
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Treatments of P. gingivalis culture supernatants and LPS preparation 
To investigate the role of P. gingivalis cysteine proteinases in TACE production, the 
P. gingivalis W50 culture supernatant was pre-treated with 1 mM of the proteinase 
inhibitor Na-p-tosyl-llysine chloromethyl ketone hydrochloride (TLCK) (Sigma-
Aldrich, Dorset, UK) for 1 h at 4˚C, prior to addition to the Jurkat cell cultures. To 
investigate the role of proteinaceous components in general, P. gingivalis W50 culture 
supernatant was heat-treated at 70°C for 1 h, in order to inactivate the protein content, 
prior to challenge of the cells. Purified P. gingivalis LPS was prepared as previously 
described  (6). 
 
Treatment of the cell cultures with doxycycline 
The effect of doxycycline on the regulation of TACE secretion by the cells was also 
investigated. For this purpose, concentrations of doxycycline (Sigma-Aldrich, Dorset, 
UK) of up-to 10 µg/ml were administered to the cells concomitantly with P. 
gingivalis, for 6 h of challenge.  
 
Cytotoxicity assay 
The cytotoxic effects of P. gingivalis on Jurkat cells were evaluated by measuring the 
extracellularly released cytosolic lactate dehydrogenase (LDH), using the colorimetric 
CytoTox96® Non-Radioactive Cytotoxicity Assay, according to the manufacturer 
(Promega, Southampton, UK). 
 
Extraction of total RNA and synthesis of cDNA 
Total RNA was extracted from cells using RNeasy Mini kit (QIAGEN, Crawley, UK) 
according to the manufacturer’s instructions. RNA was quantified using a Nanodrop 
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spectrophotrometer and reversed transcribed into cDNA. One µg of total RNA was 
incubated with 0.5 µg/ml of oligo dT primer (Promega, Southampton, UK) at 70°C 
for 5 min and cooled on ice. Master mix was added to samples, comprising of 10mM 
dNTPs, 200 units of moloney murine leukemia virus reverse-transcriptase enzyme 
and buffer (Promega, Southampton, UK), and dH20 to a final volume of 25 µl.  For 
the reverse-transcription reaction, these samples were incubated at 40°C for 60 min, 
70°C for 15 min and cooled down to 4°C.  
 
Quantitative real-time PCR (qPCR) 
Quantification of TACE mRNA expression levels in the prepared cDNA samples was 
performed by qPCR TaqMan® Gene Expression Assays (Applied Biosystems, Foster 
City, CA). The assay IDs were ADAM17/TACE: Hs01048105-m1 and 18S rRNA: 
Hs99999901-s1. The 18S rRNA served as an endogenous RNA control. For the 
amplification reactions a qPCR Master Mix was used (Abgene, Epsom, UK), and the 
qPCR analyses were performed in an ABI Prism 7900HT Sequence Detection System 
(Applied Biosystems, Foster City, CA). The amplification conditions were 10 min at 
95 °C, followed by 40 cycles at 95 °C for 15 sec and 60 °C for 1 min. The expression 
levels of TACE transcripts were calculated by using the comparative Ct method (2-∆Ct 
formula) after normalization to 18S rRNA. 
 
Determination of TACE levels by Enzyme Linked Immunosorbent Assay (ELISA) 
After 6 h of challenge with P. gingivalis culture supernatants, the Jurkat T-cell 
cultures in suspension were centrifuged at 1000 rpm for 5 min. The resulting 
supernatants were collected and TACE concentrations were evaluated a by human-
specific TACE ELISA kit, in accordance with the manufacturer’s instructions 
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(DuoSet ELISA Development kit, R&D Systems, Abington, UK). In a series of 
experiments, the cell-associated fraction was also analysed for TACE content. After 
centrifugation of the cell cultures in suspension, while the supernatant was collected 
for evaluation of secreted TACE, the cell pellets were washed with cold PBS, and 
suspended in chilled lysis buffer (150 mM Sodium dodecyl sulphate, 50 mM TRIS pH 
7.3, 2.5 % Sodium chloride, 1% NP-40), including 1:100 Protease Inhibitor Cocktail 
(Sigma, Dorset, UK), for 20 min at 4°C. The resulting cell lysates were collected and 
centrifuged at 1500 rpm for 20 min at 4°C to remove cell debris. 
 
Statistical analysis 
The significance of differences between control and test groups was assessed by one-
way analysis of variance, and Bonferroni post-hoc test. P values < 0.05 were 
considered indicative of statistical significance. The data are expressed as means ± the 
standard error of means (SEM). 
 
Results 
Jurkat T-cells were challenged with ascending protein concentrations of P. gingivalis, 
and the effect on cell death was determined after 6 h, by measuring the 
extracellularely released LDH. Bacterial concentrations equal or lower than 6.4 µg/ml 
did not elicit any cytotoxicity, compared to control (data not shown). 
The effect of P. gingivalis on TACE mRNA expression and protein secretion 
by the cells was then investigated after 6 h of challenge. Compared to the 
unchallenged control, P. gingivalis significantly enhanced TACE mRNA expression 
(Fig.1) and protein secretion (Fig. 2) in a concentration-dependent manner. 
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Indicatively, 6.4 µg/ml P. gingivalis caused a 2.3-fold up-regulation compared to the 
control. 
The next step was to identify P. gingivalis virulence factors potentially 
involved in the up-regulation of TACE. For this purpose, P. gingivalis culture 
supernatants (6.4 µg/ml) were heat-inactivated or TLCK-treated prior to challenging 
the cells, in order to destroy the proteinaceous components, or inhibit the cysteine 
proteinase activity, respectively. After 6 h of challenge, both treatments resulted in 
abolishment of TACE secretion to control levels (Fig. 3). TLCK treatment alone did 
not affect TACE secretion by the cells, compared to the control (data not shown). The 
effect of purified P. gingivalis LPS was also tested. Concentrations as high as 1000 
ng/ml failed to enhance TACE secretion, compared to the P. gingivalis culture 
supernatants (Fig. 3). 
TACE may exist in both cell-bound and secreted forms. Therefore, inhibition 
of TACE secretion upon heat- or TLCK-treatment of P. gingivalis, does not exclude 
the possibility that the production of this protein may still be induced, but instead be 
accumulated in the cell associated fraction due to inefficient shedding from the cell 
surface. To address this question, cell lysates were also collected and TACE levels 
were measured and compared to those in the corresponding the culture supernatants. 
After 6 h of challenge with P. gingivalis it was found that extracellularely released 
TACE levels were consistently higher than cell-associated levels. Interestingly, no 
statistically significant differences (P > 0.05) were observed in cell-associated TACE 
levels, between P. gingivalis-challenged and control cell cultures. Importantly, neither 
heat-, nor TLCK-treatment had significant effects on cell-associated TACE, compared 
to either un-treated P. gingivalis or control, whereas secreted TACE was consistently 
inhibited (Fig. 4). 
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Finally, the potential effect of doxycycline on TACE secretion was further 
investigated, since this pharmacological agent is known to possess anti-inflammatory 
properties. Jurkat cells were challenged for 6 h with P. gingivalis culture supernatants 
alone (6.4 µg/ml), or in combination with ascending concentrations of sub-
antimicrobial doses of doxycycline (2.5 µg/ml – 10 µg/ml). These concentrations were 
shown to be non-toxic to the cells (data not shown). It was found that the presence of 
doxycycline in culture caused a significant and dose-dependent reduction of TACE 
secretion (Fig. 5). Doxycycline alone (10 µg/ml) caused a reduction in basal levels of 
secreted TACE by 30 %, which, however, did not prove to be significant. 
 
Discussion 
This is the first study to demonstrate that P. gingivalis stimulates the mRNA 
expression and production of the zinc-dependent metalloprotease TACE by host cells. 
This property adds up to the capacity of this periodontal pathogen to modulate the 
inflammatory processes. Although P. gingivalis can regulate the expression of several 
metalloproteases, TACE is particularly important due to its capacity to shed 
membrane-bound cytokines from host cells, thus perpetuating the inflammatory 
responses.  
Since bacterial challenge has been shown to stimulate TACE production in 
other experimental systems (13, 31-33), we aimed here to further identify P. 
gingivalis virulence factors responsible for this effect. Heat-inactivation of P. 
gingivalis culture supernatants abolished its capacity to stimulate TACE secretion by 
Jurkat T-cells, indicating that the responsible component is proteinaceous. The 
involvement of cysteine proteinases was then further investigated, by chemically 
blocking their activity in P. gingivalis culture supernatants. This procedure resulted in 
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abolishment of the capacity of P. gingivalis to stimulate TACE production, 
implicating the gingipains as the responsible proteinaceous components. Purified P. 
gingivalis LPS failed to stimulate TACE secretion by the cells. To this extent, it has 
been shown the production of TACE in monocytes is not affected by Escherichia coli 
LPS (9, 34), but can be down-regulated by Salmonella typhimurium LPS (12). 
However, it should be noted that Jurkat cells do not express toll-like receptors -2 and -
4 (35), and may therefore not be responsive to LPS. 
The release of TACE from the cell surface may require the involvement of 
proteolytic processing (36, 37). Since inhibition of P. gingivalis cysteine proteases 
appears to be associated with a decrease in TACE secretion, it was postulated that 
these bacterial enzymes may act to shed the membrane-bound form of TACE, 
especially since it possesses a cysteine-rich extracellular domain. If this would have 
been the case, then inhibition of P. gingivalis gingipain activity would consequently 
result in accumulation of TACE on the cell-associated fragment, due to inefficient 
shedding. To address this possibility, the levels of both cell-associated and secreted 
TACE were measured and compared. The data showed that cell-associated levels of 
TACE were not affected by P. gingivalis challenge compared to control, indicating 
that TACE is mainly expressed in secreted form in the present experimental system. 
Importantly, abolishment of P. gingivalis gingipains by TLCK treatment did not result 
in accumulation of cell-associated TACE, compared to challenge with un-treated P. 
gingivalis. Similarly, heat-inactivation of P. gingivalis did not enhance the cell-
associated TACE levels. Hence, this data disproves the hypothesis that gingipains 
may act to shed P. gingivalis-induced TACE from the cell membrane. These findings 
indicate that the up-regulated secretion of TACE in response to P. gingivalis occurs 
through a regulatory mechanism independent of gingipain-mediated shedding from 
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the cells. A potential explanation would be the activation of proteolysis-mediated 
intracellular pathways. To this extent, gingipains have been shown to stimulate 
protease activated receptors (PARs), triggering in turn a cascade of processes which 
play important roles in the host inflammatory responses (38). 
Due to its global cytokine shedding activity, TACE has implications in a wide 
range of pathological processes, including cancer (19), respiratory infections (13), 
bacterial meningitis (32), rheumatoid arthritis (15) inflammatory demyelinating 
disorders of the peripheral nervous system (39), and periodontitis (21). Therefore, 
inhibition of TACE constitutes a putative therapeutic target for drug development. 
One of the potential approaches for TACE inhibition is the administration of 
doxycycline (28). Doxycycline possesses anti-inflammatory properties, which are 
separate and distinct from its antimicrobial action. These include the inhibition of 
cytokine and metalloprotease production (25, 40, 41), and clinical studies have 
indicated that doxycycline treatment can be beneficial in inflammatory diseases 
associated with excessive metalloprotease production (26, 42). In the present study, 
the effect of doxycycline on P. gingivalis-induced TACE production was also 
investigated. The results demonstrated that doxycycline dose-dependently inhibited 
TACE secretion in P. gingivalis-challenged cells, within a concentration range 
between 2.5 µg/ml and 10 µg/ml. This sub-antimicrobial range of doxycycline 
concentrations has been reported in GCF, gingival tissue, or plasma after oral 
administration of this drug, and is therefore of physiological relevance (43, 44). 
Therefore, the pharmacological effects of doxycycline on the inhibition of TACE 
production may justify further the role of this drug as an adjunctive treatment agent 
for periodontitis. The exact mechanism of the inhibition of P. gingivalis-induced 
TACE production by doxycycline is not clear. However, this may be attributed to the 
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anti-inflammatory properties of doxycycline, since TACE can be stimulated by pro-
inflammatory cytokines (45), and doxycyline can inhibit bacterially-induced cytokine 
production by T-cells (46). 
The present work has demonstrated that P. gingivalis stimulates TACE 
secretion by T-cells, and its gingipains appear to be responsible for this effect. 
However, their proteolytic activity is not required for cell-shedding and release of 
TACE. Therefore, gingipains may have a role in regulating the overall production of 
secreted TACE, rather than its release from the cell membrane. This does not exclude 
the possibility that other periodontal pathogens may as well induce TACE by host 
cells, via differential pathways. Bacterial stimulation of TACE secretion by T-cells 
may result in ample cytokine shedding in the periodontal tissues, thus enhancing and 
prolonging the inflammatory responses, which could lead to the establishment of a 
chronic inflammatory lesion. These findings are of potential significance to 
periodontal diseases, especially in light of recent clinical evidence demonstrating 
higher GCF levels of this molecule in periodontitis (21). 
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Figure Legends 
 
Figure 1 Effect of P. gingivalis on TACE mRNA expression by Jurkat T-cells. 
Cells were cultured in the absence or presence of ascending protein concentrations of 
P. gingivalis culture supernatants for 6 h. Cell lysates were then collected, and TACE 
mRNA expression levels were measured by qPCR analysis, normalized against the 
expression levels of 18S rRNA. The results are expressed as the ∆CT formula. The 
bars represent mean ± SEM from three individual experiments. * Statistically 
significant difference compared to control group. 
 
Figure 2 Effect of P. gingivalis on TACE secretion by Jurkat T-cells. 
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Cells were cultured in the absence or presence of ascending protein concentrations of 
P. gingivalis culture supernatants for 6 h. The cell culture supernatants were then 
collected and analysed by ELISA for TACE content. The bars represent mean ± SEM 
from three individual experiments. * Statistically significant difference compared to 
control group. 
 
Figure 3 Role of P. gingivalis proteins, cysteine proteases and LPS in TACE 
secretion. 
Cells were cultured for 6 h in the absence or presence of 6.4 µg/ml un-treated, heat-
inactivated, or TLCK-treated P. gingivalis culture supernatants, or purified P. 
gingivalis LPS (1000 ng/ml). The cell culture supernatants were then collected and 
analysed by ELISA for TACE content. The bars represent mean ± SEM from three 
individual experiments. * Statistically significant difference compared to control 
group. 
 
Figure 4 Secreted versus cell-associated TACE levels in response to P. gingivalis. 
Cells were cultured for 6 h in the absence or presence ascending concentrations of P. 
gingivalis, heat-inactivated, or TLCK-treated P. gingivalis culture supernatants (6.4 
µg/ml), or purified P. gingivalis LPS (1000 ng/ml). The cell culture supernatants, as 
well as cell lysates were then collected and analysed by ELISA for TACE content. 
The bars represent mean ± SEM from three individual experiments. * Statistically 
significant difference compared to control group. 
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Figure 5 Effect of doxycycline on P. gingivalis – stimulated TACE secretion. 
Cells were cultured for 6 h in the absence or presence of P. gingivalis culture 
supernatants (6.4 µg/ml), in combination with ascending concentrations of 
doxycycline (2.5 µg/ml – 10 µg/ml). The cell culture supernatants were then collected 
and analysed by ELISA for TACE content. The bars represent mean ± SEM from 
three individual experiments. * Statistically significant difference compared to control 
group. 
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